Kingworld Medicines Group Ltd (1110.HK) reported earnings for full year that Dropped, from the same period last year
The company's bottom line totaled RMB11.28 million, or RMB0.0192 per share. This compares with RMB41.55 million, or RMB0.0722 per share, last year.
The company's revenue for the period fell 13.5% to RMB917.34 million from RMB1.061 billion last year.
Kingworld Medicines Group Ltd earnings at a glance (GAAP) :
-Earnings: RMB11.28 Mln. vs. RMB41.55 Mln. last year.-EPS: RMB0.0192 vs. RMB0.0722 last year.-Revenue: RMB917.34 Mln vs. RMB1.061 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.